Otofarma SpA (Ticker: OTO IM) is an Italian company specializing in the hearing care sector, focusing on the production, distribution, and after-sales assistance of professional hearing aids. Otofarma plans to list on Euronext Growth Milan on August 4, 2025. The company is offering 4.0 million primary shares within an expected price range of €5.00 to €5.75 per share. This is expected to raise approximately €23 million (about $27 million). Otofarma distributes its products mainly through a network of pharmacies across Italy, utilizing telemedicine solutions. The company reported a pro-forma production value of €15.9 million for 2024. Alantra Capital Markets is acting as the manager for the offering. Before the IPO, the company is wholly owned by Bartolomucci Holding.